Markets

Insider Trading

Hedge Funds

Retirement

Opinion

10 Best Low Priced Stocks to Buy for the Next 3 Years

In this article, we will discuss the 10 Best Low Priced Stocks to Buy for the Next 3 Years.

On May 12, Chris Veronne of Strategas appeared on CNBC’s ‘Closing Bell Overtime’ to share his technical take on the current market picture. Veronne reflected on the start of the year and noted that his firm expected a melt-up driven by a new Fed Chair cutting rates into a hot economy. While the melt-up occurred, it notably happened without the Fed actually cutting rates. He identified significant shifts in the banking sector, an area where his firm had previously been unapologetically bullish for three years. He cautioned that losing the bank names or placing them on the wrong side of the ledger demands serious attention.

When asked if he is on alert regarding the broader indices, Veronne confirmed that this is the right perspective. He referenced 77.50 as a key indicator number for his firm, and though the market crossed 7,400 during the day, he believes it is premature to say they are fully in a danger zone. He expressed concern over consumer stocks, stating that conditions are bad in the consumer world. He contrasted this with the prior year’s recovery from tariff lows, which was led by a three-to-four-month discretionary rally that is completely absent in the current environment. On a positive note, Veronne finds solace in the fact that neither consumer staples nor healthcare has made significant moves, indicating that an overt defensive rotation has not yet taken place.

Our Methodology

We used screeners to identify stocks that are expected to grow their EPS by at least 30% over the next 5 years and are trading below $50 per share. We limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and are ranked in ascending order of the number of hedge funds that have stakes in them, as of Q4 2025.

Note: All data was sourced on May 18. 

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).

10 Best Low Priced Stocks to Buy for the Next 3 Years

10. Maplebear Inc. (NASDAQ:CART)

Number of Hedge Fund Holders: 50

Maplebear Inc. (NASDAQ:CART) is one of the best low priced stocks to buy for the next 3 years. On May 14, Instacart and Ace Hardware, which is the largest hardware cooperative in the world,  announced a new nationwide partnership to offer same-day delivery of tools, lawn and garden supplies, grilling equipment, and home maintenance essentials. Available via the Instacart Marketplace, the service will deliver items to customers’ doors in as fast as one hour.

The collaboration focuses on providing convenience and competitive pricing by offering Ace products with no retail markups. Representatives from both companies emphasized that this expansion allows customers to seamlessly access trusted local inventory online at standard retail costs.

With thousands of cooperative locations now active on the platform, Ace Hardware joins over 2,200 retail banners already available on the Instacart app. To mark the launch, the companies are offering a limited-time promotional discount on qualifying purchases through June 30.

Maplebear Inc. (NASDAQ:CART), doing business as Instacart, is a North American retail technology company that operates a massive online marketplace for grocery delivery and pickup, connecting customers with personal shoppers who fulfill orders from local retail stores.

9. Coeur Mining Inc. (NYSE:CDE)

Number of Hedge Fund Holders: 51

Coeur Mining Inc. (NYSE:CDE) is one of the best low priced stocks to buy for the next 3 years. On May 6, Coeur Mining reported record Q1 2026 financial results, highlighted by $856 million in revenue and a GAAP net income from continuing operations of $247 million, or $0.35 per share. Driven by rising metal prices, the company achieved record adjusted EBITDA of $475 million and grew its cash balance eleven-fold year-over-year to $843 million. This liquidity prompted an expanded $750 million share repurchase program and the initiation of a semiannual dividend policy.

Operationally, the company produced 96,503 ounces of gold and 4.4 million ounces of silver, marking double-digit year-over-year increases that align with its reaffirmed full-year 2026 guidance. Production was further bolstered by the closing of the New Gold transaction on March 20, allowing the newly acquired New Afton and Rainy River mines to contribute 14,145 ounces of gold and 1.4 million pounds of copper during the final eleven days of the quarter.

Exploration efforts yielded significant updates, including a maiden resource at New Afton’s K-Zone totaling 47.6 million tonnes of measured and indicated resources, containing an estimated 715,000 ounces of gold and 606 million pounds of copper. Additionally, an updated technical report for the Rainy River mine outlined a successful mine life expansion out to 2035, positioning Coeur Mining Inc. (NYSE:CDE) to achieve its projected record-breaking year.

Coeur Mining Inc. (NYSE:CDE) is a gold and silver producer in the US, Canada, and Mexico. The company explores for gold, silver, zinc, lead, and other related metals. It markets and sells its concentrates to third-party customers, including refiners and smelters, under off-take agreements.

8. On Holding AG (NYSE:ONON)

Number of Hedge Fund Holders: 51

On Holding (NYSE:ONON) is one of the best low priced stocks to buy for the next 3 years. On May 14, On Holdings and LOEWE, which is one of the world’s major luxury houses, announced the launch of the LightSpray Cloudmonster, a limited-release running shoe featuring On Holding’s automated, one-step manufacturing technology. The precision-engineered process sprays a seamless filament upper in approximately three minutes, eliminating the need for traditional layering.

This ultra-lightweight, laceless silhouette pairs a single-piece upper with On’s high-cushioning Cloudmonster Hyper midsole and includes specialized functional socks that alter the shoe’s appearance. The latest collaborative collection also introduces new variations of everyday movement footwear, including the co-designed Cloudsolo in fresh bicolour and exclusive single-tone palettes.

Additionally, the lineup debuts the Cloudtilt Hi, a new hi-top silhouette utilizing tricolour combinations. The product rollout is supported by a dedicated performance campaign directed by visual artist duo Blackwall. The LightSpray Cloudmonster will be sold exclusively at On Holding (NYSE:ONON) and LOEWE retail locations.

On Holding (NYSE:ONON) is a Swiss company that designs and manufactures premium athletic footwear, apparel, and accessories. The company is best known for its patented CloudTec cushioning technology.

7. Viridian Therapeutics Inc. (NASDAQ:VRDN)

Number of Hedge Fund Holders: 54

Viridian Therapeutics Inc. (NASDAQ:VRDN) is one of the best low priced stocks to buy for the next 3 years. On May 6, Viridian Therapeutics announced the pricing of upsized concurrent public offerings totaling $350 million in aggregate gross proceeds. The financing consists of $225 million in 1.75% convertible senior notes due 2032 and an equity offering of 7,352,942 shares of common stock priced at $17.00 per share. Net proceeds are estimated at $334.7 million, with underwriters granted 30-day options to purchase up to an additional $25 million in notes and 1,102,941 shares of common stock.

The convertible notes will be unsecured, senior obligations maturing on May 15, 2032, with interest payable semi-annually. The initial conversion rate is set at 40.5680 shares per $1,000 principal amount, representing an initial conversion price of approximately $24.65 per share and a 45.0% premium over the public equity offering price. Viridian retains the option to redeem the notes on or after May 20, 2030, provided its stock price exceeds 130% of the conversion price for a specified trading duration.

Viridian Therapeutics Inc. (NASDAQ:VRDN) plans to use the net proceeds to fully repay its outstanding debt with Hercules Capital Inc. The remaining capital will fund market expansion studies for its thyroid eye disease franchise, advance early-stage pipeline research, and support general working capital needs.

Viridian Therapeutics Inc. (NASDAQ:VRDN) discovers and sells treatments for rare and serious illnesses. It produces three main therapeutics: Veligrotrug, Elegrobart, and anti-thyroid-stimulating hormone receptor/TSHR. Its portfolio of engineered inhibitors of the neonatal Fc receptor (FcRn) includes VRDN-008 and VRDN-006.

6. Centuri Holdings Inc. (NYSE:CTRI)

Number of Hedge Fund Holders: 55

Centuri Holdings Inc. (NYSE:CTRI) is one of the best low priced stocks to buy for the next 3 years. On May 6, Centuri Holdings reported Q1 2026 revenue of $723.2 million, marking a 31% increase year-over-year. Gross profit surged 76% to $35.8 million, driven by growth across all operating segments and seasonal mitigation efforts. The company narrowed its net loss to $9.5 million, an $8.4 million improvement from the prior year period, while adjusted EBITDA rose 34% to $32.6 million.

During the quarter, Centuri Holdings Inc. (NYSE:CTRI) secured $1.3 billion in total bookings, propelled by a mix of new bid awards and Master Service Agreement/MSA renewals. This commercial momentum expanded the company’s backlog to a record $6.5 billion, representing a 44% year-over-year increase. Management subsequently reaffirmed its full-year 2026 guidance, expecting total revenue between $3.24 billion and $3.54 billion.

Alongside earnings, the company introduced its “Vision One Centuri” strategic plan and established long-term financial targets through 2029. These targets project a base revenue CAGR of 10% to 15% and a target base gross profit margin of 8.7% to 9.7% by 2029. The strategy focuses on core capabilities, adjacent market expansion, and strengthening resource delivery to drive profitable growth.

Centuri Holdings Inc. (NYSE:CTRI) operates as a utility infrastructure services company in North America. The company has four segments: US Gas Utility Services, Canadian Gas Utility Services, Union Electric Utility Services, and Non-Union Electric Utility Services.

While we acknowledge the potential of CTRI to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CTRI and that has 100x upside potential, check out our report about the cheapest AI stock.

Click to continue reading and see the 5 Best Low Priced Stocks to Buy for the Next 3 Years.

Disclosure: None. None. Follow Insider Monkey on Google News.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.